Analystreport

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $77.00 price t

Arcturus Therapeutics Holdings Inc.  (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations